Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADDvise Group | 27,041,270 | net | 23 Jan 2026 | tx 12+55,713,018−28,671,748 |
| Sedana medical | 2,270,594 | net | 20 Jun 2017 | tx 8+2,270,594 |
| Boule Diagnostics AB | 1,549,063 | net | 30 Nov 2022 | tx 14+2,260,848−711,785 |
| Surgical Science Sweden AB | 397,770 | net | 28 Nov 2025 | tx 3+397,770 |
| Biotage AB | -61,538 | net | 07 May 2020 | tx 2−61,538 |
| swedencare | 59,060 | net | 16 Feb 2026 | tx 3+59,060 |
| Scibase Holding AB | -56,085 | net | 20 Nov 2017 | tx 3−56,085 |
| Calliditas Therapeutics ab | -21,250 | net | 04 Dec 2019 | tx 2−21,250 |
| Biotage AB | -15,000 | net | 05 Oct 2020 | tx 1−15,000 |
| Moberg Pharma AB | 14,251 | net | 05 Mar 2018 | tx 2+14,251 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Feb 2026 | PURCHASE | swedencare | 42,918 | 23.30 SEK | |
| 23 Jan 2026 | SALE | ADDvise Group | 711,081 | 1.72 SEK | |
| 23 Jan 2026 | SALE | ADDvise Group | 4,496,638 | 0.52 SEK | deriv |
| 23 Jan 2026 | SALE | ADDvise Group | 143,188 | 0.52 SEK | deriv |
| 23 Jan 2026 | SALE | ADDvise Group | 23,320,841 | 1.72 SEK | |
| 26 Nov 2025 | PURCHASE | Surgical Science Sweden AB | 49,807 | 28.87 SEK | |
| 27 Nov 2025 | PURCHASE | Surgical Science Sweden AB | 262,588 | 31.78 SEK | |
| 28 Nov 2025 | PURCHASE | Surgical Science Sweden AB | 85,375 | 32.40 SEK | |
| 05 May 2025 | PURCHASE | ADDvise Group | 1,304,348 | 0.00 SEK | |
| 25 Apr 2025 | PURCHASE | ADDvise Group | 153,339 | 0.00 SEK | deriv |
| 25 Apr 2025 | PURCHASE | ADDvise Group | 4,593,615 | 0.00 SEK | deriv |
| 24 Apr 2025 | PURCHASE | swedencare | 12,560 | 33.95 SEK | |
| 16 Apr 2025 | PURCHASE | ADDvise Group | 9,364,360 | 1.15 SEK | |
| 07 Apr 2025 | PURCHASE | ADDvise Group | 195,444 | 1.15 SEK | |
| 07 Apr 2025 | PURCHASE | ADDvise Group | 19,808,727 | 1.15 SEK | |
| 07 Jun 2023 | PURCHASE | swedencare | 3,582 | 41.76 SEK | |
| 29 Nov 2022 | PURCHASE | Boule Diagnostics AB | 851,916 | 7.70 SEK | |
| 30 Nov 2022 | PURCHASE | Boule Diagnostics AB | 57,969 | 7.70 SEK | |
| 29 Nov 2022 | PURCHASE | Boule Diagnostics AB | 1,104,139 | 7.70 SEK | first after silence |
| 30 Nov 2022 | PURCHASE | Boule Diagnostics AB | 74,621 | 7.70 SEK | |
| 05 Oct 2020 | SALE | Biotage AB | 15,000 | 173.90 SEK | |
| 06 May 2020 | SALE | Biotage AB | 40,000 | 121.20 SEK | |
| 07 May 2020 | SALE | Biotage AB | 21,538 | 123.10 SEK | |
| 03 Dec 2019 | SALE | Calliditas Therapeutics ab | 16,000 | 67.71 SEK | |
| 04 Dec 2019 | SALE | Calliditas Therapeutics ab | 5,250 | 69.45 SEK |
2 purchases reported after at least 12 months of silence — most recent on 29 Nov 2022.